Pharmaceutical industry
The Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute (NCI), has agreed to sponsor a Phase I study of REOLYSIN alone in patients with relapsed multiple myeloma. This study is part of a larger effort to explore additional treatment options for multiple myeloma
Pharmaceutical industry
As a six-time Olympic gold medalist swimmer, I know firsthand the challenges of living with moderate to severe persistent allergic asthma. I, Amy Van Dyken, have been managing my symptoms for years, navigating the complexities of treatment options, and learning to take charge of my health. Key Takeaways: * I have
Pharmaceutical industry
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) has assumed development of R343, an inhaled syk inhibitor for allergic asthma, following Pfizer's decision to exit the allergy and respiratory therapeutic area. Rigel plans to design a Phase 2 clinical trial with R343 later this year. R343 is a promising therapeutic that
Pharmaceutical industry
Diamyd Medical AB, a Swedish pharmaceutical company, has announced that its antigen-based therapy Diamyd has failed to meet the primary efficacy endpoint in a European phase III clinical trial for newly diagnosed type 1 diabetes patients. The trial, which enrolled over 320 patients between the ages of 10 and 20,
Pharmaceutical industry
The NASDAQ Stock Market kicked off the trading session with significant gains in several companies, while others faced setbacks. Oncothyreon, Affymetrix, USA Technologies, BroadSoft, and MannKind were among the leading gainers, with Oncothyreon's stock jumping 10.74 percent to $4.95. Affymetrix reported a major milestone with the
Pharmaceutical industry
A collaborative study between scientists from the University Campus Bio-Medico in Rome, Italy, and Generex's subsidiary, Antigen Express, Inc., has published results in the April issue of Hormone and Metabolism Research. The study, entitled "Recognition of Ii-Key/MHC Class II Epitope Hybrids Derived from Proinsulin and GAD
Pharmaceutical industry
The Nasdaq Stock Exchange has listed the 20 most gainer companies in a recent update, reflecting the significant growth of various enterprises across the globe. The list includes a diverse range of companies from different sectors, with intriguing changes in their stock prices, reflecting the dynamic nature of the global
Pharmaceutical industry
The U.S. Food and Drug Administration (FDA) has approved Rituxan, a therapeutic antibody, in combination with corticosteroids, as a new medicine for adults with Wegener's Granulomatosis (WG) and Microscopic Polyangiitis (MPA). These rare autoimmune diseases affect the small blood vessels of the kidneys, lungs, sinuses, and other
Pharmaceutical industry
Marina Biotech, a leading RNAi-based drug discovery and development company, has announced the publication of data highlighting the application of their proprietary DiLA2-based delivery technology for systemic administration of siRNAs. The research, published in Molecular Therapy, describes the development of an amphoteric DiLA2 delivery system that enables efficient knockdown of
Pharmaceutical industry
Marina Biotech, a leading RNAi-based drug discovery and development company, has announced the completion of enrollment in the first cohort of its START-FAP, Phase 1b/2a clinical trial with CEQ508. This milestone marks a significant step forward in the development of a novel therapeutic agent for Familial Adenomatous Polyposis (FAP)
Pharmaceutical industry
Merck and Johnson & Johnson have reached an agreement to amend the distribution rights to REMICADE and SIMPONI, two medications used to treat chronic inflammatory diseases such as rheumatoid arthritis. The agreement comes after an arbitration proceeding initiated by Johnson & Johnson in May 2009, following the announcement of the
Pharmaceutical industry
Researchers in the United States have reported a breakthrough in the field of biotechnology, discovering the therapeutic potential of extremolytes, novel compounds derived from extremophiles, micro-organisms that can survive in extreme conditions. These compounds, with potential applications in human therapeutics, are being investigated for their anticancer properties, antioxidants, and other
